58 related articles for article (PubMed ID: 9820617)
1.
Zhang HF; Huang SL; Wang WL; Zhou YQ; Jiang J; Dai ZJ
World J Clin Cases; 2024 May; 12(15):2627-2635. PubMed ID: 38817239
[TBL] [Abstract][Full Text] [Related]
2. RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions.
Hamidi S; Hu MI
Ann Endocrinol (Paris); 2024 Apr; 85(2):118-126. PubMed ID: 38342224
[TBL] [Abstract][Full Text] [Related]
3. [Multiple endocrine neoplasia and very early onset inflammatory bowel disease. An unexpected association].
Rossi SI; Baleani S; Prado X; Pascual C; Tennina C; Malagrino P; Vieites A; Parra A; Cazalla M; Castano JT; Lapunzina P
Medicina (B Aires); 2024; 84(2):347-350. PubMed ID: 38683522
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia 2A presenting in a family with a history of Hirschprung's disease.
Johns AM; Vuong AH; Hassan OA; Randle RW; Gorris MA
Oxf Med Case Reports; 2021; 2021(11-12):omab122. PubMed ID: 34987852
[TBL] [Abstract][Full Text] [Related]
5. Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study.
Holm M; Vestergaard P; Poulsen MM; Rasmussen ÅK; Feldt-Rasmussen U; Bay M; Rolighed L; Londero S; Pedersen HB; Hahn CH; Rask KB; Nielsen HH; Gaustadnes M; Rossing MC; Hermann AP; Godballe C; Mathiesen JS
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046785
[TBL] [Abstract][Full Text] [Related]
6. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.
Nosé V; Gill A; Teijeiro JMC; Perren A; Erickson L
Endocr Pathol; 2022 Mar; 33(1):197-227. PubMed ID: 35285003
[TBL] [Abstract][Full Text] [Related]
7. 5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.
Li SY; Ding YQ; Si YL; Ye MJ; Xu CM; Qi XP
Front Endocrinol (Lausanne); 2020; 11():543246. PubMed ID: 33071967
[TBL] [Abstract][Full Text] [Related]
8. The RET C611Y mutation causes MEN 2A and associated cutaneous.
Qi XP; Peng JZ; Yang XW; Zao ZL; Yu XH; Fang XD; Zhang DH; Zhao JQ
Endocr Connect; 2018 Sep; 7(9):998-1005. PubMed ID: 30300539
[TBL] [Abstract][Full Text] [Related]
9. MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.
Scapineli JO; Ceolin L; Puñales MK; Dora JM; Maia AL
Fam Cancer; 2016 Oct; 15(4):625-33. PubMed ID: 26920351
[TBL] [Abstract][Full Text] [Related]
10. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
Qi XP; Zhao JQ; Chen ZG; Cao JL; Du J; Liu NF; Li F; Sheng M; Fu E; Guo J; Jia H; Zhang YM; Ma JM
Oncotarget; 2015 Oct; 6(32):33993-4003. PubMed ID: 26356818
[TBL] [Abstract][Full Text] [Related]
11. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
Wang J; Zhang B; Liu W; Zhang Y; Di X; Yang Y; Yan D
Fam Cancer; 2016 Jan; 15(1):99-104. PubMed ID: 26254625
[TBL] [Abstract][Full Text] [Related]
12. Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe.
Alevizaki M
Thyroid Res; 2013 Mar; 6 Suppl 1(Suppl 1):S10. PubMed ID: 23514325
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 2.
Peczkowska M; Januszewicz A
Fam Cancer; 2005; 4(1):25-36. PubMed ID: 15883707
[TBL] [Abstract][Full Text] [Related]
14. Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma.
Karga HJ; Karayianni MK; Linos DA; Tseleni SC; Karaiskos KD; Papapetrou PD
Eur J Endocrinol; 1998 Oct; 139(4):410-5. PubMed ID: 9820617
[TBL] [Abstract][Full Text] [Related]
15. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
[TBL] [Abstract][Full Text] [Related]
16. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
17. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
18. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
